Services Conditions Science Mission Support Providers

A New MUSE for Medicine? The Truth About Regenerative Medicine's Most Talked-About Cell

← All articles

frontotemporal dementia

0 articles

No articles found for this topic yet.

Browse all articles

Explore more topics

Adipose Derived Mesenchymal Stromal Cells Adipose Derived Stem Cells Aging ALZ / Alzheimers Amyloid Beta Anal Incontinence Antidiabetic Drug Development Asherman Syndrome autoimmune disease Autoimmune Disorders Autologous Cell Therapy Autologous Hematopoietic Cell Transplantation Autologous Stem Cells Autologous Therapies Autologous Transfusion Betulinic Acid Bioavailability blog Blood Body Contouring Bone Marrow Bsep Transporter Cancer Stem Cells Cardiac Regeneration Cartilage Lesions Cartilage Preservation Cartilage Regeneration Cartilage Repair Cd34 Hematopoietic Stem Cells Cellular Expansion

Stay in touch

Ask another AI

Services

Blood Storage
Fibroblast Storage
Stem Cell Storage
The Complete Baseline

Shop

Annual plan
Lifetime plan
Client Login
Scheduler Login

Learn

Articles
Conditions Guide
Evidence Room
Blog
Podcast
FAQ
ISO Accredited

Careers

About us
Privacy policy
Press
Terms of Use

Questions

Clinics & Locations
For physicians
Partner with us
Careers
Contact us
(888) 732-2375

Own Your Biology. Forever.

Get the Forever app

App Store Google Play

Follow Us

Facebook X Instagram LinkedIn YouTube Linktree

FDA, cell therapies and genomic data

The U.S. Food and Drug Administration (FDA) regulates stem cell therapies as biological products to ensure their safety and efficacy. The FDA requires that stem cell therapies undergo rigorous clinical trials to demonstrate safety and effectiveness before approval. Patients considering stem cell treatments should consult with their healthcare providers about FDA-approved options and be cautious of unproven therapies that have not undergone proper regulatory review. The Complete Baseline is a wellness record reviewed by a board-certified physician partner. It is not a diagnosis.